Results from randomized noninferiority #PRECISION trial on MRI +/- targeted biopsy vs. standard TRUS–guided biopsy for #ProstateCancer detection in men w/ elevated PSA who did not previously undergo biopsy. #EAU18 @NEJM https://t.co/MiPUa58ucy
Results from randomized noninferiority #PRECISION trial on MRI +/- targeted biopsy vs. standard TRUS–guided biopsy for #ProstateCancer detection in men w/ elevated PSA who did not previously undergo biopsy. #EAU18 @NEJM
https://t.co/MiPUa58ucy